Seven new members were recently elected to serve on the board of trustees of University of the Sciences. The responsibilities of the University’s board include approving the University’s strategic plans and ensuring their consistency with the institution’s mission and goals.
Stephanie Bean PT’89, DPT, joins the board as the alumni representative. Dr. Bean brings 23 years of experience in physical therapy and is currently physical therapist at Christine Hayes, PT in Paoli, Pa. Prior to her current position, Dr. Bean worked in a variety of clinical settings as well as an adjunct faculty member at USciences. She is also serving in 2013-14 as the immediate past president of the USciences Alumni Association having been president one year prior.
Schumarry H. Chao, MD, MBA, is a former trustee of USciences, who completed her board service at the end of fiscal year 2012. Currently, Dr. Chao serves as owner and president of SHC-PMAC Inc., a consulting firm located in Las Vegas, Nev. For the past 30 years, Dr. Chao has enjoyed a career in care management and has served in senior executive positions with Aetna, University of Southern California, and Security Pacific. In pursuit of her interest in teaching and research, she also holds positions of clinical professor in emergency medicine and family medicine as well as adjunct professor in pharmaco-economics in the School of Pharmacy at University of Southern California. Additionally, she was chief medical officer for the Los Angeles Summer Olympic and senior vice president of strategic development and chief medical officer for MedImpact Healthcare Systems
John Daly, MD, is emeritus dean at Temple University’s School of Medicine. Under his leadership as dean of Temple’s medical school from November 2002 to March 2011, the school added a clinical and basic science department; 300 new faculty and 21 department chairs, chiefs’ and center directors; and completely revamped the medical curriculum to meet changing educational paradigms. The medical school became highly ranked by U.S. News and World Report due to a tripling of research funding. A new building, the largest capital improvement in Temple’s history, opened in May 2009. Dr. Daly specializes in surgical oncology and has been certified by the American Board of Surgery most recently in 2009.
Rose Mary B. Hoy P’82, RPh, is currently the national pharmacy sales director for Merck Vaccines. Hoy has been with Merck for 31 years, with previous responsibilities in sales, marketing, and manufacturing. She received her pharmacy degree from the former Philadelphia College of Pharmacy and Science in 1982, and also attended the Wharton School of Business. Hoy actively supports the USciences student chapter of the Academy of Managed Care Pharmacy in her role as diplomat, and she frequently lectures to students about careers in pharmacy. Hoy was on the board last year as the alumni representative.
Rev. Cedric H. Jones, Jr., MDiv, MBA, BS in chemical engineering, is the senior pastor of the Mount Zion Baptist Church of Philadelphia, serving as the fourth pastor in the church's 99-year history. The large, growing urban congregation has community ministries in health, education, and economics. Previously, he was an engineer, marketer, and commercial executive at Johnson & Johnson and Procter & Gamble for over 20 years. He led several pharmaceutical and consumer healthcare businesses as a worldwide vice president, vice president of marketing, executive director of sales and business development, and product director. Pastor Jones' extensive background in education includes doctoral studies, appointment to the strategic planning committee of Wissahickon School District, co-instructing graduate students of education, serving on the president's council of a graduate seminary, teaching clergy at seminaries, and conducting seminars on leadership to business executives.
Thomas J. Kingston, Jr., MEd, was named interim vice president for finance and administration at USciences on Jan. 3, 2013, and completed his appointment on June 30, 2013, that year. Kingston served as vice president for finance and administration at Franklin & Marshall College from 1995 to 2008 where he led all of F&M's business and finance operations and is now an emeritus vice president. He was also vice president for business and finance at Philadelphia University from 1985 to 1995. Since leaving F&M, Kingston also served as interim vice president for finance at Loyola University Maryland (June 2010 to May 2011) and returned in an interim role to F&M (June 2011 to December 2011).
Kent E. Lieginger, PharmD, is senior vice president for managed care and customer operations at Genentech Inc. as well as director of the Genentech Foundation. He joined Genentech as vice president of managed care and customer operations in December 2004. He also serves as a member of Genentech’s commercial leadership committee. Prior to joining Genentech, Dr. Lieginger was vice president of national insurer and employer segment (managed markets division) at GlaxoSmithKline, where he also led teams in U.S. and global business development, finance, strategic contracting, manufacturing, marketing, and sales. He completed his residency in clinical pharmacy at the University of California in San Francisco and served for four years as assistant clinical professor of medicine at the University of California, Davis School of Medicine.